Macquarie Group LTD Amneal Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $3,401 - $6,096	-1,684 Closed	0 $3,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $3,782 - $5,889	-798 Reduced 32.15%	1,684 $11,000
Q2 2020 Aug 11, 2020	BUY	$2.87 - $5.46 $7,123 - $13,551	2,482 New	2,482 $12,000
Q3 2018 Nov 15, 2018	SELL	$16.4 - $24.27 $506,759 - $749,943	-30,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $431,055 - $624,180	30,900 New	30,900 $507,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.36B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.